Mankind Pharma Limited
MANKIND
Rang în acțiuni
#2049
Mankind Pharma Limited specializes in the development, manufacturing, and... Mankind Pharma Limited specializes in the development, manufacturing, and marketing of a broad range of pharmaceutical medications and consumer health goods. Operating predominantly in India, the company also caters to international markets. Its pharmaceutical division focuses on both acute and chronic therapeutic areas, encompassing a wide spectrum of medical conditions such as infectious diseases, cardiovascular ailments, gastrointestinal disorders, diabetes, dermatology, pain management, neuro/CNS issues, nutritional support (vitamins/minerals), and respiratory problems. Complementing its pharmaceutical portfolio, the consumer healthcare segment offers diverse products, including condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and mineral supplements, and anti-acne preparations. Key brands under its umbrella include Manforce, Prega News, Unwanted-72, Gas-O-Fas, Health OK, and AcneStar. Furthermore, the company's business activities are diversified, extending to the trading and export of pharmaceutical and healthcare products, as well as the manufacturing of various goods such as packaging materials, ayurvedic products, bulk drugs, and general consumer items. Mankind Pharma also holds interests in real estate, leasing, hospitality, and IT services. Established in 1986, Mankind Pharma Limited maintains its headquarters in New Delhi, India.
Preț acțiune
$24.08
Capitalizare de piață
$9.95B
Schimbare (1 zi)
-4.09%
Schimbare (1 an)
-13.33%
Țară
IN
Tranzacționează Mankind Pharma Limited (MANKIND)
Categorie
Healthcare
Raport P/B pentru Mankind Pharma Limited (MANKIND)
Raport P/B la data de October 2026 TTM: 5.67
Conform celor mai recente rapoarte financiare și prețului acțiunilor Mankind Pharma Limited, raportul P/B actual (TTM) este 5.67. La sfârșitul anului 2025, compania avea un P/B de 6.94.
Istoricul raportului P/B pentru Mankind Pharma Limited din 2019 până în 2026
Raport P/B la sfârșitul fiecărui an
| An | Raport P/B | Schimbă |
|---|---|---|
| 2026 (TTM) | 5.67 | -18.26% |
| 2025 | 6.94 | -29.83% |
| 2024 | 9.89 | 29.08% |
| 2023 | 7.66 | -17.22% |
| 2022 | 9.26 | -23.28% |
| 2021 | 12.07 | -26.19% |
| 2020 | 16.35 | -19.00% |
| 2019 | 20.18 | 0.00% |
Raport P/B pentru companii similare sau competitoare
| Companie | Raport P/B | Diferență raport P/B | Țara |
|---|---|---|---|
| 1.9834 | -65.04% |
DE
|
|
| 2.1139 | -62.73% |
DE
|
|
| 1.3124 | -76.86% |
JP
|
|
| 6.3468 | 11.89% |
CH
|
|
| 5.041 | -11.13% |
IN
|
